Literature DB >> 2806927

Effect of levodopa on the human pattern electroretinogram and pattern visual evoked potentials.

I Gottlob1, H Weghaupt, C Vass, E Auff.   

Abstract

Pattern electroretinograms (P-ERGs) and pattern visual evoked potentials (P-VEPs) were recorded at three luminance levels and five different check sizes in a group of 16 control subjects before and after the oral administration of levodopa. At the lower luminance levels, significant decrease in P-ERG and P-VEP latencies were found. For P-VEPs the latency changes occurred only at small check sizes. No changes were observed in control experiments without levodopa administration. Our results show that levodopa-induced changes even occur at the retinal level and support a dopaminergic involvement in light and dark adaptation. Our observations are in agreement with a VEP delay found in Parkinson's disease and with a VEP latency increase in rats after dopamine depletion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2806927     DOI: 10.1007/bf02172892

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  31 in total

1.  Light stimulates tyrosine hydroxylase activity and dopamine synthesis in retinal amacrine neurons.

Authors:  P M Iuvone; C L Galli; C K Garrison-Gund; N H Neff
Journal:  Science       Date:  1978-11-24       Impact factor: 47.728

2.  Some evidence for the existence of dopaminergic neurons in the rat cortex.

Authors:  A M Thierry; L Stinus; G Blanc; J Glowinski
Journal:  Brain Res       Date:  1973-02-14       Impact factor: 3.252

3.  The demonstration of several neurotransmitter and drug receptors in human retina.

Authors:  H O Borbe; K J Fehske; W E Müller; A Nover; U Woller
Journal:  Comp Biochem Physiol C       Date:  1982

4.  Possible indication of dopaminergic blockade in man by electroretinography.

Authors:  V Filip; J Balík
Journal:  Int Pharmacopsychiatry       Date:  1978

5.  Dopaminergic deficiency and delayed visual evoked potentials in humans.

Authors:  I Bodis-Wollner; M D Yahr; L Mylin; J Thornton
Journal:  Ann Neurol       Date:  1982-05       Impact factor: 10.422

6.  Pattern evoked potentials (PEPs) in Parkinson's disease.

Authors:  D S Dinner; H Lüders; M Hanson; R P Lesser; G Klem
Journal:  Neurology       Date:  1985-04       Impact factor: 9.910

7.  Temporal frequency-dependent VEP changes in Parkinson's disease.

Authors:  M Marx; I Bodis-Wollner; P Bobak; C Harnois; L Mylin; M Yahr
Journal:  Vision Res       Date:  1986       Impact factor: 1.886

8.  Effects of light on dopamine metabolism in the chick retina.

Authors:  D Parkinson; R R Rando
Journal:  J Neurochem       Date:  1983-01       Impact factor: 5.372

9.  Alteration of visual evoked potentials and electroretinograms in Parkinson's disease.

Authors:  I Gottlob; E Schneider; W Heider; W Skrandies
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1987-04
View more
  8 in total

1.  Electrophysiological assessment of glaucomatous visual dysfunction during treatment with cytidine-5'-diphosphocholine (citicoline): a study of 8 years of follow-up.

Authors:  Vincenzo Parisi
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

2.  Influence of dopamine deficiency in early Parkinson's disease on the slow stimulation multifocal-ERG.

Authors:  Anja M Palmowski-Wolfe; Maria Timoner Perez; Stefanie Behnke; Gerhard Fuss; Martin Martziniak; Klaus W Ruprecht
Journal:  Doc Ophthalmol       Date:  2006-06-22       Impact factor: 2.379

3.  Effect of L-dopa on pattern visual evoked potentials (P-100) and neuropsychological tests in untreated adult patients with phenylketonuria.

Authors:  K Ullrich; J Weglage; C Oberwittler; M Pietsch; B Fünders; H van Eckhardstein; J P Colombo
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

4.  Regional Downregulation of Dopamine Receptor D1 in Bilateral Dorsal Lateral Geniculate Nucleus of Monocular Form-Deprived Amblyopia Models.

Authors:  Dongyue Lin; Zhonghao Wang; Wei Chen; Tao Shen; Xuan Qiu; Kun Wei; Jiahui Li; Dongsheng Yang; Ping Wang; Xuri Li; Jianhua Yan; Zhongshu Tang
Journal:  Front Neurosci       Date:  2022-06-08       Impact factor: 5.152

5.  Remodeling of the fovea in Parkinson disease.

Authors:  B Spund; Y Ding; T Liu; I Selesnick; S Glazman; E M Shrier; I Bodis-Wollner
Journal:  J Neural Transm (Vienna)       Date:  2012-12-23       Impact factor: 3.575

6.  Effect of levodopa on the human dark adaptation threshold.

Authors:  I Gottlob; K Strenn; B Schneider
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-10       Impact factor: 3.117

Review 7.  The role of drug treatment in children with strabismus and amblyopia.

Authors:  K I Chatzistefanou; M D Mills
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.930

8.  Effectiveness and safety of topical levodopa in a chick model of myopia.

Authors:  Kate Thomson; Cindy Karouta; Ian Morgan; Tamsin Kelly; Regan Ashby
Journal:  Sci Rep       Date:  2019-12-04       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.